Macrogenics, Inc. share price logo

Macrogenics, Inc. Share Price

NASDAQ: MGNX

Small Cap

$1.54

+0.07

(+4.76%)

as on

Macrogenics, Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.48
    $1.62
    downward going graph

    3.90%

    Downside

    5.19%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.99
    $5.1
    downward going graph

    35.74%

    Downside

    231.17%

    Upside

    downward going graph

Macrogenics, Inc. share price movements today

Previous Close
$1.47
Open
$1.49
Volume
1.1M
Day's Low - High
$1.48 - $1.62
52 Week Low - High
$0.99 - $5.1

Macrogenics, Inc. Historical Returns

1 Month Return
-6.96 %
3 Month Return
+ 7.3 %
1 Year Return
-56.32 %
3 Year Return
-57.39 %
5 Year Return
-95.29 %

Macrogenics, Inc. Stock Fundamentals & Key Indicators

Check Macrogenics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$92.9M

EPS (TTM)

-1.71

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.21%

PE Ratio (TTM)

-1.6

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

0.01

EBITDA

-70.5M

Revenue (TTM)

165.5M

Profit Margin

-21.99%

Return On Equity TTM

1724470900.00%

Macrogenics, Inc. Stock Valuation

Track how Macrogenics, Inc. P/E has moved over time to understand its valuation trends.

Macrogenics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-1.60x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.60x

Macrogenics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Macrogenics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$92.9M-95.29%-1.6-21.99%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Macrogenics, Inc. Stock including INR - Dollar returns

The Macrogenics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Macrogenics, Inc. investment value today

Current value as on today

₹50,296

Returns

₹49,704

(-49.7%)

Returns from Macrogenics, Inc. Stock

₹54,303 (-54.3%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Macrogenics, Inc. Stock

Based on 18 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Macrogenics, Inc.. Average target price of $3.4

Macrogenics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Macrogenics, Inc..

What analysts predicted

54.71%UPSIDE

Target Price

$3.4

Current Price

$1.54

Analyzed by

18 Analysts

Target

$3.40

Macrogenics, Inc. target price $3.4, a slight upside of 54.71% compared to current price of $1.54. According to 18 analysts rating.

Macrogenics, Inc. Stock's Interest Amongst Investors

Search interest for Macrogenics, Inc. Stock has increased by 180% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:180% versus previous 30 day period

Macrogenics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
24
13
10
10
9
10
110
17
13
22
Gross Profit
20
11
10
8
6
7
108
12
7
13
Operating Income
-38
-44
-35
-49
-53
-58
54
-52
-42
-36
EBITDA
-34
61
19
-44
-49
-53
58
-12
-39
-33
Interest Expense
0
0
-
2
1
0
-
0
0
0
Depreciation
2
2
1
1
1
1
1
2
1
1
Income Before Tax
-38
57
17
-46
-52
-55
56
-14
-41
-36
Income Tax Expense
0
-1
-1
3
1
-
-1
0
-
0
Net Income
-38
57
17
-46
-52
-55
56
-15
-41
-36
Net Profit Margin
-157.96%
437.49%
168.84%
-429.78%
-573.26%
-515.55%
50.86%
-86.98%
-311.07%
-162.99%

Macrogenics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
100
86
155
60
62
97
75
151
57
148
Gross Profit
100
86
155
60
-133
97
72
144
48
136
Operating Income
-20
-60
-22
-171
-177
-131
-202
-121
-168
-110
EBITDA
-17
-52
-14
-162
-177
-119
-191
-109
2
-57
Interest Expense
-
-
-
-
-
-
0
0
1
1
Depreciation
-
-
7
8
10
11
11
11
9
7
Income Before Tax
-20
-58
-19
-171
-151
-129
-202
-119
-9
-66
Income Tax Expense
-
-7
-7
0
10
-11
-11
0
9
0
Net Income
-20
-58
-19
-171
-151
-117
-190
-120
-9
-66
Net Profit Margin
-19.97%
-67.60%
-12.62%
-285.18%
-244.76%
-120.48%
-252.31%
-78.99%
-15.84%
-45.14%

Macrogenics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
57
17
-46
-52
-55
56
-15
-41
-36
Operating Cash Flow
-2
-35
-28
-45
-44
60
-38
-46
-46
Investing Cash Flow
-113
-33
38
24
47
35
41
9
-37
Financing Cash Flow
0
49
0
0
0
0
0
0
69
Change in Cash
-115
-18
11
-20
3
95
3
-37
-14

Macrogenics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-58
-19
-171
-151
-129
-202
-119
-9
-66
Operating Cash Flow
-43
14
-153
-134
-111
-143
-86
-78
-68
Investing Cash Flow
-70
77
56
-79
-7
-36
70
-80
149
Financing Cash Flow
1
35
104
119
174
122
1
150
0
Change in Cash
-112
127
8
-93
54
-57
-14
-7
81

Global Institutional Holdings in Macrogenics, Inc.

Funds
Holdings
Bellevue Group AG
15.74%
Armistice Capital, LLC
9.98%
BlackRock Inc
7.79%
Vanguard Group Inc
7.02%
Wasatch Advisors LP
5.15%

Insights on Macrogenics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 13.19M → 22.24M (in $), with an average increase of 40.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -41.03M → -36.25M (in $), with an average increase of 13.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 124.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 173.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MGNX stock has moved down by -10.9%

About Macrogenics, Inc.

a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to novel cancer targets, as well as “bio-betters,” which are drugs designed to improve upon marketed medicines. the combination of macrogenics’ technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. these are exciting times at macrogenics and we hope that you will take the opportunity to learn more about our organization, our pipeline and to view our job opportunities!
OrganisationMacrogenics, Inc.
Headquarters9704 Medical Center Drive, Rockville, MD, United States, 20850
IndustryHealth Technology
CEOMr. Eric Blasius Risser
E-voting on sharesClick here to vote

Key Management of Macrogenics, Inc.

Name

Title

Dr. Stephen L. Eck M.D., Ph.D.

Senior VP of Clinical Development & Chief Medical Officer

Dr. Thomas M. Spitznagel Ph.D.

Senior Vice President of Technical Operations

Mr. Jeffrey Stuart Peters J.D.

Senior VP, General Counsel & Corporate Compliance Officer

Ms. Beth Smith

VP, Controller & Treasurer

Mr. James Karrels

Senior VP, CFO & Corporate Secretary

Mr. Eric Blasius Risser

CEO, President & Director

Dr. Ezio Bonvini M.D.

Senior VP of Research & Chief Scientific Officer

Mr. Steve Harig

Senior Vice President of Human Resources

Mr. Harish Krishnaswamy

Senior Vice President of Business Development & Portfolio Planning

FAQs

What is Macrogenics, Inc. share price today?

Macrogenics, Inc. share price today is $1.54 as on at the close of the market. Macrogenics, Inc. share today touched a day high of $1.62 and a low of $1.48.

What is the 52 week high and 52 week low for Macrogenics, Inc. share?

Macrogenics, Inc. share touched a 52 week high of $5.1 on and a 52 week low of $0.99 on . Macrogenics, Inc. stock price today i.e. is closed at $1.54,which is 69.80% down from its 52 week high and 55.61% up from its 52 week low.

What is Macrogenics, Inc.'s market capitalisation today?

Macrogenics, Inc. market capitalisation is $0.00T as on .

How to invest in Macrogenics, Inc. Stock (MGNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Macrogenics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Macrogenics, Inc. Shares that will get you 0.9740 shares as per Macrogenics, Inc. share price of $1.54 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Macrogenics, Inc. Stock (MGNX) from India?

Indian investors can start investing in Macrogenics, Inc. (MGNX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Macrogenics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Macrogenics, Inc. share’s latest price of $1.54 as on September 18, 2025 at 1:29 am IST, you will get 6.4935 shares of Macrogenics, Inc.. Learn more about fractional shares .

What are the returns that Macrogenics, Inc. has given to Indian investors in the last 5 years?

Macrogenics, Inc. stock has given -95.29% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?